¶¶Òõpro

Profile (Gabriela Kaynor)

  • Executive Officer and Chief Strategy Officer Gabriela Kaynor

    Date of birth: November 20, 1975

April 2025 Chairman, ¶¶Òõpro of the Americas (present)
April 2024
  • Executive Officer, Chief Strategy Officer, ¶¶Òõpro (present)
  • Director, ¶¶Òõpro of Asia Pacific Limited (present)
April 2023 Executive Officer, Therapeutic Solutions Division Head, ¶¶Òõpro
April 2022
  • Corporate Officer, ¶¶Òõpro
  • Director, ¶¶Òõpro of the Americas (present)
April 2020 Global Division Head Therapeutic Solutions Division, ¶¶Òõpro
April 2019 Senior Vice President, Global Portfolio Management, Strategy & PMO Therapeutic Solutions Division, ¶¶Òõpro
July 2017 Vice President, Upstream Marketing & PMO, ¶¶Òõpro of the Americas
April 2016
  • Joined ¶¶Òõpro of the Americas
  • Executive Director Strategy Development & Portfolio Management, ¶¶Òõpro of the Americas
February 2015 Director, Operations, Acclarent, Inc. (Part of the Johnson & Johnson family of companies)
February 2012 Director Program Management Office & Advanced Supplier Development, Cardinal Health, Inc. (formerly Covidien plc)
July 2008 R&D Director Monitoring & OR Products, SharpSafety, Cardinal Health, Inc. (formerly Covidien plc)
February 2007 Engineering Manager, Johnson & Johnson Services, Inc.
May 2004 Business Unit Manager, Johnson & Johnson Services, Inc.
April 2000 Joined Johnson & Johnson Services, Inc..

Top Management